Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 38 Records) |
| Query Trace: Oligodendroglioma and IDH1[original query] |
|---|
| Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients. World journal of surgical oncology 2013 11 (1): 284. Takahashi Yoshinobu, Nakamura Hideo, Makino Keishi, Hide Takuichiro, Muta Daisuke, Kamada Hajime, Kuratsu Jun-Ic |
| Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China. Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
| Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
| ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta neuropathologica 2015 Jan 129 (1): 133-46. Reuss David E, Sahm Felix, Schrimpf Daniel, Wiestler Benedikt, Capper David, Koelsche Christian, Schweizer Leonille, Korshunov Andrey, Jones David T W, Hovestadt Volker, Mittelbronn Michel, Schittenhelm Jens, Herold-Mende Christel, Unterberg Andreas, Platten Michael, Weller Michael, Wick Wolfgang, Pfister Stefan M, von Deimling Andre |
| Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients. Asian Pacific journal of cancer prevention : APJCP 2013 14 (12): 7261-4. Das Bibhu Ranjan, Tangri Rajiv, Ahmad Firoz, Roy Arnab, Patole Kamlak |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene. Genes, chromosomes & cancer 2015 Nov 54 (11): 655-67. Lhotska Halka, Zemanova Zuzana, Cechova Hana, Ransdorfova Sarka, Lizcova Libuse, Kramar Filip, Krejcik Zdenek, Svobodova Karla, Bystricka Dagmar, Hrabal Petr, Dohnalova Alena, Michalova Ky |
| IDH1 and IDH2 mutations in different histologic subtypes and WHO grading gliomas in a sample from Northern Brazil. Genetics and molecular research : GMR 2015 14 (2): 6533-42. Pessôa I A, Sagica F E S, Anselmo N P, Brito J R N, de Oliveira E H |
| Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas. Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
| Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas. Histopathology 2015 May . Hewer Ekkehard, Vajtai Istvan, Dettmer Matthias S, Berezowska Sabina, Vassella Er |
| The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients. Turkish neurosurgery 2016 Aug . Hacisalihoglu Payam, Kucukodaci Zafer, Gundogdu Gokcen, Bilgic Bil |
| Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco. Asian Pacific journal of cancer prevention : APJCP 2016 17 (5): 2649-53. Senhaji Nadia, Louati Sara, Chbani Laila, Bardai Sanae El, Mikou Karima, Maaroufi Mustafa, Benzagmout Mohammed, Faiz Mohammed Chaoui El, Marie Yannick, Mokhtari Karima, Idbaih Ahmed, Amarti Afaf, Bennis San |
| ATRX immunostaining predicts IDH and H3F3A status in gliomas. Acta neuropathologica communications 2016 4 (1): 60. Ebrahimi Azadeh, Skardelly Marco, Bonzheim Irina, Ott Ines, Mühleisen Helmut, Eckert Franziska, Tabatabai Ghazaleh, Schittenhelm Je |
| Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas. Medicine 2016 Mar 95 (9): e2583. Chen Jun-Rui, Yao Yu, Xu Hong-Zhi, Qin Zhi-Yo |
| Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach. Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
| Anatomic mapping of molecular subtypes in diffuse glioma. BMC neurology 2017 9 17 (1): 183. Tang Qisheng, Lian Yuxi, Yu Jinhua, Wang Yuanyuan, Shi Zhifeng, Chen Lia |
| [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 9 47 (9): 658-663. Liu Q Q, Yin X X, Zou Y, Yu T P, Gong J, Chen X Q, Nie L, Xu M, Zhang M N, Zhou Q, Chen |
| Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 4 24 (12): 2812-2819. Martínez-Ricarte Francisco, Mayor Regina, Martínez-Sáez Elena, Rubio-Pérez Carlota, Pineda Estela, Cordero Esteban, Cicuéndez Marta, Poca Maria A, López-Bigas Nuria, Ramon Y Cajal Santiago, Vieito María, Carles Joan, Tabernero Josep, Vivancos Ana, Gallego Soledad, Graus Francesc, Sahuquillo Juan, Seoane Jo |
| von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
| The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database. BMC cancer 2019 Mar 19 (1): 190. Hummel Sarah, Kohlmann Wendy, Kollmeyer Thomas M, Jenkins Robert, Sonnen Joshua, Palmer Cheryl A, Colman Howard, Abbott Diana, Cannon-Albright Lisa, Cohen Adam |
| Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas. Chinese medical journal 2019 Dec . Wang Lei-Ming, Li Zhuo, Piao Yue-Shan, Cai Yan-Ning, Zhang Li-Yan, Ge Hai-Jing, Xu Wei-Wei, Lu De-Ho |
| Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma. PeerJ 2019 7 e7414. Zhu Jin, Zhang Yu- |
| Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC cancer 2021 Sep 21 (1): 1025. Makino Yasuhide, Arakawa Yoshiki, Yoshioka Ema, Shofuda Tomoko, Minamiguchi Sachiko, Kawauchi Takeshi, Tanji Masahiro, Kanematsu Daisuke, Nonaka Masahiro, Okita Yoshiko, Kodama Yoshinori, Mano Masayuki, Hirose Takanori, Mineharu Yohei, Miyamoto Susumu, Kanemura Yonehi |
| Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
| Seizure in Indonesian Glioma Patients: Associated Risk Factors and Impact on Survival. Asian Pacific journal of cancer prevention : APJCP 2021 3 22 (3): 691-697. Hartanto Rahmat Andi, Dwianingsih Ery Kus, Panggabean Andre Stefanus, Wicaksono Adiguno Suryo, Dananjoyo Kusumo, Asmedi Ahmad, Malueka Rusdy Ghaza |
| Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion. World neurosurgery 2021 2 149 e1174-e1179. Zhu Jin, Hu Li-Bo, Zhao Ya-Peng, Zhang Yu- |
| The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma. Epilepsy & behavior reports 2022 2 18 100526. Vo Anh Huan, Ambady Prakash, Spencer Dav |
| CIMP-positive glioma is associated with better prognosis: A systematic analysis. Medicine 2022 Sep 101 (39): e30635. Xu Yingying, Xiao Huashi, Hu Wenqing, Shen He-Chun, Liu Wanjun, Tan Siyuan, Ren Chuanli, Zhang Xiaomin, Yang Xishuai, Yu Guo, Yang Ting, Yu Duonan, Zong Lia |
| Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
| Molecular Pathology of Gliomas. Clinics in laboratory medicine 2024 5 44 (2): 149-159. Kristyn Galbraith, Matija Snude |
- Page last reviewed:Feb 1, 2024
- Content source: